It is possible that STC1 and PENK could act in concert towards differentiation, with additional contribution from many other differentially expressed candidate genes between CD49a+ prostate and CD13+ bladder stromal cells [2], between CD49a+ prostate stromal and CD90+ cancer-associated stromal cells [11]. The gene discussed is STC1; the disease is cancer.